Type 2 diabetes drugs Ozempic and Mounjaro are among the 775 brand-name drugs with higher prices in 2024, The Wall Street Journal reported Jan. 18.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Ozempic, Mounjaro become pricier
